FIRST-LINE CHEMOTHERAPY IN THE RETREATMENT OF BACTERIOLOGICAL RELAPSES OF PULMONARY TUBERCULOSIS FOLLOWING A SHORT-COURSE REGIMEN: HONG KONG TUBERCULOSIS TREATMENT SERVICES AND EAST AFRICAN AND BRITISH MEDICAL RESEARCH COUNCILS
- 24 January 1976
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 307 (7952) , 162-163
- https://doi.org/10.1016/s0140-6736(76)91271-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong KongTubercle, 1975
- FOLLOW-UP OF PATIENTS WITH PULMONARY TUBERCULOSIS ADEQUATELY TREATED BY CHEMOTHERAPY: IS THIS REALLY NECESSARY ?The Lancet, 1974
- Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in east Africa third report of fifth investigationTubercle, 1973
- Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation: A report to the Medical Research Council by their Tuberculosis Chemotherapy Trials CommitteeTubercle, 1962